CMRX 241115 3.00P (CMRX241115P3000) Stock Options, News & Quotes

0.00
0.000.00%

15min DelayClose Nov 15 09:30 ET

0.00High0.00Low

SymbolStock Name

Latest PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry

WatchlistPaper Trade

Comments

Jaguar8

Nov 11 06:01

NEWS

$Chimerix (CMRX.US)$
Chimerix Announces Updated Phase 2 Response Assessment of Dordaviprone in Recurrent H3 K27M Glioma at the 2024 SNO Meeting
Chimerix (NASDAQ: CMRX) announced updated Phase 2 response assessment results for dordaviprone in treating recurrent H3 K27M-mutant diffuse midline glioma. Using the new RANO 2.0 criteria, the treatment showed a 28.0% overall response rate, with a median time to response of 4.6 months and a median duration of response of 10.4 months. The company plans...

101674396

Oct 28 11:57

$Chimerix (CMRX.US)$ …why high peak?

Goldman Sachs

Aug 20 15:05

Tonix initiates Phase II trial for emergency cocaine intoxication treatment
$Tonix Pharmaceuticals (TNXP.US)$

101674396

Aug 20 03:47

$Chimerix (CMRX.US)$ .. supposed be rise…but drop !!!!

Analysts Notebook

Aug 19 08:18

Columns Monkeypox Outbreak Drove Surge in These Company Shares

As health authorities worldwide work to contain the monkeypox outbreak, investors quickly buy shares in companies that might profit from efforts to control the disease.
Investors are buying up shares of vaccine producers, antiviral drug makers, and protective equipment companies, hoping to profit as they did during the coronavirus pandemic.
Bavarian Nordic, the only producer approved of the pox vaccine, saw its shares jump 16.5% on the day in...